Aspire Biopharma Holdings (ASBP) Retained Earnings (2021 - 2026)
Aspire Biopharma Holdings (ASBP) posted quarterly Retained Earnings of $34.3 million for Q1 2026, up 283.5% year-over-year from $9.0 million in Q1 2025, and up 64.49% quarter-over-quarter from $20.9 million in Q4 2025.
Aspire Biopharma Holdings (ASBP) Retained Earnings (2021 - 2026) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has reported Retained Earnings for 6 consecutive years, with $34.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings rose 283.5% year-over-year to $34.3 million; the TTM figure through Mar 2026 stood at $34.3 million (up 283.5% YoY), while the FY2025 annual figure was $20.9 million, up 1587.99% from the prior year.
- Retained Earnings rose to $34.3 million in Q1 2026 per ASBP's latest filing, from $20.9 million in the prior quarter.
- Across five years, Retained Earnings topped out at $34.3 million in Q1 2026 and bottomed at -$22.6 million in Q3 2025.
- Historically, Retained Earnings has averaged -$5.2 million across 5 years, with a median of -$10.1 million in 2022.
- Annual changes were most pronounced in 2022 — Retained Earnings tumbled 41031.67% — and 2025, when it jumped 1587.99%.
- Aspire Biopharma Holdings' Retained Earnings stood at -$9.9 million in 2022, then slipped by 13.57% to -$11.3 million in 2023, then jumped by 110.96% to $1.2 million in 2024, then surged by 1587.99% to $20.9 million in 2025, then soared by 64.49% to $34.3 million in 2026.
- Business Quant data shows ASBP's Retained Earnings at $34.3 million in Q1 2026, $20.9 million in Q4 2025, and -$22.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | Aspire Biopharma Holdings | 8.30 Mn | -3.86 Mn | -30,086.00 | 43.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.51 Mn |
| Mar 31, 2026 | 34.35 Mn |
| Dec 31, 2025 | 20.88 Mn |
| Sep 30, 2025 | -22.55 Mn |
| Jun 30, 2025 | 11.08 Mn |
| Mar 31, 2025 | -18.72 Mn |
| Dec 31, 2024 | 1.24 Mn |
| Jun 30, 2024 | -14.76 Mn |
| Mar 31, 2024 | -13.99 Mn |
| Dec 31, 2023 | -11.29 Mn |
| Sep 30, 2023 | -10.88 Mn |
| Jun 30, 2023 | -10.55 Mn |
| Mar 31, 2023 | -10.26 Mn |
| Dec 31, 2022 | -9.94 Mn |
| Sep 30, 2022 | -9.62 Mn |
| Jun 30, 2022 | -9.37 Mn |
| Mar 31, 2022 | -9.05 Mn |
| Dec 31, 2021 | 24,281.00 |